baber/WOPTO huggingface dataset:
Patent JP-2643598-B2 (JP)
IPC: C07K19/00
Filed: 1990-01-16
Granted: 1997-08-20
Abstract: The present invention relates to a method for the detection HTLV-1 reactive antibodies and diagnosis of ATL (adult T cell leukemia/lymphoma) condition by the use of chemically synthesized peptide compositions. The peptide compositions comprise peptides having amino acid sequences corresponding to transmembrane and external segments of the envelope protein of HTLV-1 and mixtures thereof. The peptide compsitions are highly immunoreactive with antibodies in sera of patients with ATL. The present invention further relates to a method for the simultaneous detection and diagnosis of ATL and Acquired Immune Deficiency Syndrome (AIDS) by the use of chemically synthesized HTLV-1 peptide compositions in conjunction with a chemically synthesized HIV (1 and 2) peptide composition. The detection method includes an enzyme-linked immunosorbent assay (ELISA), an immunoradiometric assay (RMA), and other forms of immunoassay procedures such as enzyme immuno blotting assay on nitrocellulose paper and hemagglutination assay using the petide composition as the antigen. The preferred detection method is ELISA.
Patent JP-2801051-B2 (JP)
IPC: C12Q1/68
Filed: 1989-06-16
Granted: 1998-09-21
Abstract: The invention is directed to a method for detecting a target nucleic acid sequence. The method may employ both an amplification procedure and a detection procedure. Amplification is accomplished through the use of a plurality of pairs of nucleic acid amplification probes, wherein the member probes of each pair of amplification probes are complementary to each other with at least one hybridizing member of each pair of amplification probes also being complementary to a given portion of the target nucleic acid sequence, which acts as a template. The hybridizing members of each pair of amplification probes hybridize to the target sequence in a contiguous manner, sufficiently adjacent to each other to enable the probes to be joined together to form an amplification product. Once the hybridizing amplification probes are joined, the completed amplification product can be separated by denaturation, and the process repeated, until a sufficient quantity of the target nucleic acid sequence is produced to result in measurable signal in the selected assay. The correctly assembled amplification product serves as a template in a manner similar to that served by the target nucleic acid sequence in the amplification procedure.
Patent JP-2628230-B2 (JP)
IPC: C08L1/28
Filed: 1992-11-18
Granted: 1997-07-09
Abstract: A particulate co-processed unattrited microcrystalline cellulose:hydrocolloid composition wherein the respective components are present in a weight ratio of from about 99:1 to 70:30. The composition is useful as a spheronizing agent for producing spheroids of uniform size and sphericity and having high drug loadings. The composition is produced by drying a slurry of the microcrystalline cellulose in an aqueous solution of the hydrocolloid. The preferred hydrocolloid is methylcellulose.
Patent JP-3290990-B2 (JP)
IPC: H04B7/04
Filed: 1994-10-28
Granted: 2002-06-10
Abstract: A method for achieving the soft or softer handoff process such that the performance of a system is improved is based on delaying the softer handoff process. <??>Reverse link demodulation in each sector may continue with or without the transmission of the forward link. The operation could be based on the signal strength of the reverse link signal or the forward link. It is also possible to combine two or more methods to create a hybrid symbol. <IMAGE>
Patent JP-3191111-B2 (JP)
IPC: C12N9/62
Filed: 1990-10-12
Granted: 2001-07-23
Abstract: The invention is based on the finding that furin belongs to a family of endoproteolytically active enzymes and relates to a process for the in vitro cleavage of a protein by treating the protein in the presence of Ca<2+> ions with furin or a furin-like enzyme, or an endoproteolytically active fragment, derivative or fusion protein of furin or furin-like enzyme. The invention can be used for the (micro)biological production of a protein by culturing genetically engineered cells expressing a pro-form of the protein as well as furin or a furin-like enzyme and isolating the protein formed.
Patent JP-3583129-B2 (JP)
IPC: C04B35/638
Filed: 1994-01-12
Granted: 2004-10-27
Abstract: PCT No. PCT/EP94/00072 Sec. 371 Date Aug. 10, 1995 Sec. 102(e) Date Aug. 10, 1995 PCT Filed Jan. 12, 1994 PCT Pub. No. WO94/25205 PCT Pub. Date Nov. 10, 1994Sintered moldings are produced by molding a mixture of a sinterable ceramic or metallic powder and polyoxymethylene or a copolymer containing a majority of oxymethylene units as binder to give a compact, removing the binder by treatment with a gaseous acid, and sintering the product, which comprises removing the binder using an acid which is solid at room temperature and sublimes or melts and evaporates at elevated temperatures.
Patent JP-4063878-B2 (JP)
IPC: A61P5/00
Filed: 1996-12-19
Granted: 2008-03-19
Abstract: The fusion protein may be expressed from a polynucleotide having a promoter element and/or a transcription termination sequence, in each case operatively associated with a polynucleotide encoding the fusion protein. The yeast may be  S. cerevisiae, S. pombe, Pichia (Hansenula) sp.  or  Kluyveromyces sp.
Patent JP-3891588-B2 (JP)
IPC: G11B27/30
Filed: 1996-03-11
Granted: 2007-03-14
Abstract: A recording apparatus, for recording an information signal in at least one track on a record carrier. The information signal comprises packets (Pi) that may occur irregularly as a function of time in the serial datastream of the information signal. The apparatus comprises an input terminal for receiving the information signal, a channel encoding unit for channel encoding the information signal into a channel encoded information signal and a writing unit for writing the channel encoded information signal in said at least one track on the record carrier. The channel encoded information signal comprises frames of information. A frame of information may be recorded in a group of n subsequent tracks (Tr0 to Tr11), when the recording apparatus is a recording apparatus of the helical scan type, where n is an integer larger than 1. The apparatus further comprises a time stamp generator unit for generating time stamps (TSi) having a relation to the moment of occurrence of a packet comprised in the information signal received. Further, a combining unit is present for combining a packet and its corresponding time stamp so as to obtain a composite packet (Pi'). The time stamp generator unit comprises a counter for generating subsequent cycles of subsequent count values, said cycles coinciding in time with the recording of subsequent frames in said at least one track on the record carrier. In response to the detection of the occurrence of a packet in said information signal, a time stamp for said packet is generated, which time stamp has a specified relationship to the count value of said counter means at said moment of occurrence of said packet.
Patent JP-4027978-B2 (JP)
IPC: D01F2/06
Filed: 1997-03-10
Granted: 2007-12-26
Abstract: Irradiated woodpulp can be converted by a viscose manufacturing process into viscose wherein the ratio of alkali to cellulose is in the range from 0.37 to 0.50. The viscose has good filterability and can be coagulated and regenerated to form elongate cellulose members, in particular fibres and films
Patent JP-4369996-B2 (JP)
IPC: D02G3/40
Filed: 1997-04-16
Granted: 2009-11-25
Abstract: PCT No. PCT/IB97/00413 Sec. 371 Date Nov. 5, 1998 Sec. 102(e) Date Nov. 5, 1998 PCT Filed Apr. 16, 1997 PCT Pub. No. WO97/42363 PCT Pub. Date Nov. 13, 1997A composite yarn includes a core composed of a continuous yarn, and a coated sheath composed of a matrix including at least one chlorinated polymer material, and a fire-retarding filler incorporated into and distributed within said matrix, wherein, in combination, the fire-retarding filler comprises a ternary composition which combines an oxygenated antimony compound, a hydrated metal oxide, the metal of which is chosen from aluminum, magnesium, tin, zinc and lead, and a zinc borate and, together with said ternary composition, the total weight content of inorganic matter in the yarn is between 4% and 65%.
Patent JP-3414757-B2 (JP)
IPC: A61C13/265
Filed: 1998-05-20
Granted: 2003-06-09
Abstract: A device for forming a dental prosthesis includes a support and an element which can be attached thereto, such as an impression element. The support has an anchoring part for anchoring in a bone or a master model, a shoulder with an annular shoulder surface, and a head. The impression element has an elastically deformable fixing agent. When the device is assembled, the fixing agent jams and/or latches with the support, either externally on the support, on the side of the shoulder facing the anchoring part, or in an axial hole of the support. The element can be quickly detachably connected to the support by placing it on top of the support, and can be quickly separated from the support by moving the support away. When the device is assembled, the support and the element can lay on top of each other with annular surfaces. The annular surfaces have fully circular outer edges which are visible from the outside in an approximately radial viewing direction.
Patent JP-4124828-B2 (JP)
IPC: B03B5/00
Filed: 1998-05-20
Granted: 2008-07-23
Abstract: In the arrangement, the cross section of a blade rotating close to the surface of a screen cylinder changes in such a way that as the pulp consistency changes in the vertical direction of the screen cylinder, the cross section of the blade also changes in order to operate as efficiently as possible according to the pulp consistency by the blade.
Patent AU-2001263183-B2 (AU)
Title: Cng3b: a novel cyclic nucleotide-gated cation channel
Inventor: JEGLA TIMOTHY JAMES
IPC: C07K14/705
Filed: 2001-05-15
Granted: 2006-06-22
Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG3B, antibodies to CNG3B, methods of detecting CNG3B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG3B. The invention further provides, in a computer system, a method of screening for mutations of human CNG3B genes as well as a method for identifying a three-dimensional structure of human CNG3B polypeptides.
Patent AU-2001268727-B2 (AU)
Title: Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
Inventor: YIN ZHIWEI
IPC: C07D401/04
Filed: 2001-06-26
Granted: 2005-03-24
Abstract: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and mthod of use. In particular, the invention is converned with indoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. Mor particularly, the present invention relates to the treatment of HIV and AIDS.
Patent AU-2002338488-B2 (AU)
Title: Liquid formulations for dermal application in treatment of parasitic insects in animals
Inventor: SIRINYAN KIRKOR
IPC: C07D401/06
Filed: 2002-04-02
Granted: 2007-10-04
Abstract: The present invention relates to novel skin-friendly dermally applicable liquid formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects for controlling parasitic insects on animals.
Patent AU-2002338873-B2 (AU)
Title: Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
Inventor: DONNET-HUGHES ANNE
IPC: A61P29/00
Filed: 2002-04-23
Granted: 2008-04-10
Abstract: The invention relates to a composition for modulating the immune responses induced by Gram negative bacteria, potential pathogenic Gram positive bacteria and/or their derivatives, comprising lipoteichoic acid from lactic acid bacteria as an active ingredient. It also relates to the use of a lipoteichoic acid from lactic acid bacteria as an active ingredient and/or lactic acid bacteria producing it and/or its supernatant of culture, in the manufacture of a medicament, an oral or topical product for cosmetic, dermatological or ophthalmological applications, a food or petfood composition for modulating bacterial colonisation, immune responses and decreasing the inflammatory processes associated with bacterially-mediated disease and infection in the gastrointestinal tract, bone, skin, eye, ear, lung and oral cavity. The invention also relates to lipoteichoic acid selected thereof.
Patent AU-2003200811-B2 (AU)
Title: Storage Cartridge for Biosensors
Inventor: CHARLTON STEVEN C
IPC: G01N33/487
Filed: 2003-03-05
Granted: 2009-04-23
Abstract: A storage cartridge for dispensing biosensors used in the determination of an analyte in body fluid comprises a hollow body for housing a stack of biosensors having an open top, a flexible conveying member disposed over the open top of the body, the flexible conveying member having an aperture formed therein for receiving a biosensor from the stack of biosensors, a plate adapted to press the sliding conveying member against the open top to form a substantially moisture-impervious seal around the open top of the body and to permit the conveying member to slide between the plate and the open top, and means for biasing the stack of biosensors towards the open top. <IMAGE>
Patent AU-2003203652-B2 (AU)
Title: Autologous bone graft material
Inventor: KADIYALA SUDHAKAN
IPC: A61F2/08
Filed: 2003-03-31
Granted: 2008-07-10
Abstract: This invention relates to a musculoskeletogenic MSG graft composite made from whole bone marrow aspirate BMA having native levels of musculoskeletal progenitor cells MSPCs, comprising:  a) a suspension of fractionated BMA comprising:  i) MSPCs present at a level greater than their native level in whole BMA, and  ii) red blood cells RBCs present at a level less than their native level in whole BMA, and    b) a porous sterile matrix having an average pore size of at least 20 µm.
Patent AU-2004203727-B2 (AU)
Title: Method for manufacturing recombinant polyclonal proteins
Inventor: SHARON JACQUELINE
IPC: C07K16/18
Filed: 2004-01-07
Granted: 2008-01-31
Abstract: The invention relates to a method for manufacturing a recombinant polyclonal protein composition, in particular a recombinant polyclonal antibody composition. The method comprises obtaining a collection of cells transfected with a library of variant nucleic acid sequences, wherein each cell in the collection is transfected with and capable of expressing one member of the library, which encodes a distinct member of a polyclonal protein that binds a particular antigen and which is located at the same single site in the genome of individual cells in said collection, wherein said nucleic acid sequence is not naturally associated with said cell in the collection. The cells are cultured under suitable conditions for expression of the polyclonal protein, which is obtained from the cells or culture supernatant. The nucleic acid sequence is introduced into the cells by transfection with a library of vectors for site-specific integration. The present method is suitable for manufacturing recombinant polyclonal antibodies, thereby making available a superior replacement of plasma-derived therapeutic immunoglobulin products.
Patent AU-2004248703-B2 (AU)
Title: Power control for a mobile radio communication system
Inventor: BREUER VOLKER
IPC: H04B7/005
Filed: 2004-06-11
Granted: 2008-07-17
Abstract: A communication system having a plurality of common channels and includes a primary common control physical channel, a plurality of dedicated channels and a synchronization channel (SCH). The primary common control physical channel and the synchronization channel are transmitted time multiplexed, and the sum transmit power of dedicated channels is reduced during the transmission of the synchronization channel in order to keep the total output power at the base station power amplifier below a maximum power limit.
Patent AU-2005205781-B2 (AU)
Title: Stent with optimal strength and radio-opacity characteristics
Inventor: FISCHELL DAVID R
IPC: A61F2/06
Filed: 2005-09-01
Granted: 2007-01-04
Abstract: A stent in the form of a thin-walled, multi-cellular tubular structure is provided. The tubular structure has a longitudinal axis and the stent includes a plurality of circumferential sets of strut members. Each set of the strut members is longitudinally displaced from each other and connected to each other by longitudinally extending links. Each set of the strut members forms a closed and cylindrical portion of the stent. Further, each set of the strut members includes a plurality of connected curve sections and diagonal sections. The sets of the strut members further include end sets of strut members located at each end of the stent and central sets of strut members located between the end sets of the strut members. The diagonal sections of the end sets of the strut members have a center portion and two ends. At least one of the diagonal sections of the end sets of the strut members includes a tapered shape with width of one diagonal section is greater at the center of the diagonal section than the width at either end of the diagonal section. <IMAGE>
Patent AU-2006201690-B2 (AU)
Title: Gaming Machine with multiple reel matrix
Inventor: OSAMU YOSHIMI
IPC: A63F13/00
Filed: 2006-04-21
Granted: 2011-08-18
Abstract: - Z23 A bonus feature for a gaming machine having a display window in which additional graphic features are displayed as overlays of the graphic imagery of the base game in the 5 display window, said graphic imagery of said base game comprising symbols arranged in a first matrix of symbol containing elements wherein the elements in the base game are bounded by hexagonal figures and are staggered to allow nesting of contiguous hexagonal elements and wherein the 10 first matrix of symbol containing elements are arranged into a plurality of parallel columns that rotates as a plurality of simulated inner reels through the display window, wherein each column of symbols of the columns of said first matrix comprises at least a three symbol containing elements of the 15 rotatable inner reel, said additional graphic features comprising symbols in selected elements of a second matrix of elements wherein the second matrix of symbol containing elements are arranged into a plurality of parallel columns that rotate as a plurality of simulated outer reels through 20 the display window so as to overlie the one or more of the plurality of inner reels wherein the plurality of simulated outer reels that are selected from a plurality of sets of simulated outer reels said set of simulated outer reels being selected from a plurality of sets of predetermined simulated 25 outer reels, a random selection determining which set of said plurality of sets of pre-determined simulated outer reels is used for said bonus feature for each play of said base game and wherein a predetermined arrangement of said additional graphic feature trigger at least one bonus feature game and 30 wherein the set of simulated inner reels rotate at a first rotational speed during play of the game and wherein the set of simulated outer reels rotate at a second rotational speed during play of the game so that elements of one or more of the plurality of sets of outer reels may be in registration - Z-,+ M with elements of one or more of the plurality of inner sets of reels when the elements are rotating through the window wherein when the elements are in registration, the registered elements of the outer and inner reel rotate through the 5 display window at the same speed so as to maintain the registration therebetween while visible during the display window.
Patent AU-2006252495-B2 (AU)
Title: Side branch stent graft
Inventor: KRASNODAR IVANCEV
IPC: A61F2/06
Filed: 2006-06-01
Granted: 2011-07-07
Abstract: A side branch stent graft (1) suitable for the iliac arteries has a main tubular body (3) of a biocompatible graft material and a tubular side branch (5). The tubular side branch is affixed into the main tubular body so that a side branch lumen is in fluid communication with a main lumen. There is at least one external zig-zag stent (13) on the main tubular body proximal of the tubular side branch, one central external stent (14) which also encompasses the side arm, at least one external zig-zag stent (16) on the main tubular body distal of the tubular side branch and one internal zig-zag stent (15) at the distal end of the main tubular body. A reinforcing ring (9) is around the proximal end of the main tubular body and stitched thereto.
Patent AU-2006308718-B2 (AU)
Title: Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
Inventor: SATHYAN GAYTRI
IPC: A61K31/44
Filed: 2006-10-31
Granted: 2013-01-10
Abstract: Disclosed are methods of sustained release administration of opioids, including but not limited to hydromorphone and oxycodone, that exhibit improved properties with respect to co-ingestion with aqueous alcohol.
Patent AU-2006348679-B2 (AU)
Title: Solar powered security system
Inventor: HOUSTON ROBERT
IPC: G08B13/18
Filed: 2006-09-25
Granted: 2013-06-27
Abstract: A solar powered perimeter beam security system comprising a plurality of spaced towers. The towers have detection beams extending between them for detecting an intruder when at least one of the detection beams is interrupted. Each of the towers communicates with a remote unit.
Patent AU-2007202822-B2 (AU)
Title: Grill
Inventor: REISCHMANN MICHAEL
IPC: A47J37/06
Filed: 2007-06-18
Granted: 2009-12-03
Abstract: The invention relates to a grill (10) having a heating element (20) for heating food, a cooking grate (30) positioned above the heating element and having a plurality of openings (34) for permitting grease to pass where the plurality of openings are arranged around the heating element (20), and a touch control (40) for adjusting a temperature of said heating element. The touch control (40) has an increase button (42) to elevate the temperature of the heating element and a decrease button (44) to lower the temperature of the heating element. The touch control (40) also has a plurality of lights (50) arranged in sequential order from a first light (51) to an nth light, wherein manipulation of the increase button (41) or decrease button (44) commences illumination.
Patent AU-2007211918-B2 (AU)
Title: Method and system for accessing subterranean deposits from the surface
Inventor: ZUPANICK JOSEPH A
IPC: E21B47/09
Filed: 2007-08-24
Granted: 2008-09-18
Abstract: Improved method and system subterranean deposits from the surface that substantially eliminates or reduces the disadvantages and problems associated with previous systems and methods. In particular, the present invention provides an articulated well with a drainage pattern that intersects a horizontal cavity well. The drainage patterns provide access to a large subterranean area from the surface while the vertical cavity well allows entrained water, hydrocarbons, and other deposits to be efficiently removed and/or produced.
Patent AU-2007237339-B2 (AU)
Title: ECG lead set and ECG adapter system
Inventor: BURNES LEE C
IPC: A61B5/308
Filed: 2007-12-04
Granted: 2013-08-15
Abstract: ECG LEAD SET AND ECG ADAPTER SYSTEM A method for coupling an ECG monitor (10) with an incompatible ECG lead set (120, 130) includes the steps of providing an ECG adapter (110) including an adapter body having at least one monitor connector adapted for coupling to an input of an ECG monitor (20) and at least one lead set receptacle (I 12a, I 12b) adapted for coupling to a connector of an ECG lead set incompatible with the input of the ECG monitor, coupling the at least one monitor connector of the adapter (110) body with the input of the ECG monitor and coupling the at least one lead set receptacle of the adapter body with the connector of the ECG lead set to thereby electrically couple the ECG lead set with the ECG monitor (20). 20- Y12a- 11 131 -120 112b 130--. 140 120 120b 121a 120a 121b 121c -120e 121d 140 1200 121e 150a 12 1300.150b .D 130 A 150r